← Evidence map

ArticlePloS one2024

Correction: Enhancement of oral bioavailability of ibrutinib using a liposil nanohybrid delivery system.

PLOS ONE StaffPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39661590